
David Stone
ANOTHER SETBACK for hapless businessman David Stone, whose efforts to rescue one of his many companies has just fallen flat. For many, it is not Stone’s eclectic mix of investments that would be recognised but rather the headlines he made in 2023 as a result of his conviction for allowing the euthanasia drug pentobarbital to… Read more »
This content is only available to Phoenix subscribers.














